United States Anticoagulants Market Report & Forecast 2021-2027

United States Anticoagulants Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Anticoagulants Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Anticoagulants Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Anticoagulants Overall Market Size
2.1 United States Anticoagulants Market Size: 2021 VS 2027
2.2 United States Anticoagulants Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anticoagulants Players in United States Market
3.2 Top United States Anticoagulants Companies Ranked by Revenue
3.3 United States Anticoagulants Revenue by Companies
3.4 Top 3 and Top 5 Anticoagulants Companies in United States Market, by Revenue in 2020
3.5 Companies Anticoagulants Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anticoagulants Players in United States Market
3.6.1 List of Tier 1 Anticoagulants Companies in United States
3.6.2 List of Tier 2 and Tier 3 Anticoagulants Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Anticoagulants Market Size Markets, 2021 & 2027
4.1.2 Platelet Aggregation Inhibitors (PAI)
4.1.3 Low-Molecular-Weight Heparin (LMWH)
4.1.4 Direct Thrombin Inhibitor (DTI)
4.1.5 Direct Factor Xa Inhibitors (DFXa)
4.1.6 Vitamin K antagonists (VKA)
4.1.7 Others
4.2 By Type - United States Anticoagulants Revenue & Forecasts
4.2.1 By Type - United States Anticoagulants Revenue, 2016-2021
4.2.2 By Type - United States Anticoagulants Revenue, 2022-2027
4.2.3 By Type - United States Anticoagulants Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Anticoagulants Market Size, 2021 & 2027
5.1.2 VTE
5.1.3 ACS/MI
5.1.4 AF
5.1.5 Others
5.2 By Application - United States Anticoagulants Revenue & Forecasts
5.2.1 By Application - United States Anticoagulants Revenue, 2016-2021
5.2.2 By Application - United States Anticoagulants Revenue, 2022-2027
5.2.3 By Application - United States Anticoagulants Revenue Market Share, 2016-2027
6 Anticoagulants Companies Profiles
6.1 Sanofi
6.1.1 Sanofi Company Details
6.1.2 Sanofi Business Overview
6.1.3 Sanofi Anticoagulants Introduction
6.1.4 Sanofi Anticoagulants Revenue in United States Market (2016-2021)
6.1.5 Sanofi Recent Developments
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Company Details
6.2.2 Bristol-Myers Squibb Business Overview
6.2.3 Bristol-Myers Squibb Anticoagulants Introduction
6.2.4 Bristol-Myers Squibb Anticoagulants Revenue in United States Market (2016-2021)
6.2.5 Bristol-Myers Squibb Recent Developments
6.3 Bayer
6.3.1 Bayer Company Details
6.3.2 Bayer Business Overview
6.3.3 Bayer Anticoagulants Introduction
6.3.4 Bayer Anticoagulants Revenue in United States Market (2016-2021)
6.3.5 Bayer Recent Developments
6.4 Johnson & Johnson.
6.4.1 Johnson & Johnson. Company Details
6.4.2 Johnson & Johnson. Business Overview
6.4.3 Johnson & Johnson. Anticoagulants Introduction
6.4.4 Johnson & Johnson. Anticoagulants Revenue in United States Market (2016-2021)
6.4.5 Johnson & Johnson. Recent Developments
6.5 Genentech (Roche)
6.5.1 Genentech (Roche) Company Details
6.5.2 Genentech (Roche) Business Overview
6.5.3 Genentech (Roche) Anticoagulants Introduction
6.5.4 Genentech (Roche) Anticoagulants Revenue in United States Market (2016-2021)
6.5.5 Genentech (Roche) Recent Developments
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Company Details
6.6.2 Boehringer Ingelheim Business Overview
6.6.3 Boehringer Ingelheim Anticoagulants Introduction
6.6.4 Boehringer Ingelheim Anticoagulants Revenue in United States Market (2016-2021)
6.6.5 Boehringer Ingelheim Recent Developments
6.7 Lilly
6.7.1 Lilly Company Details
6.7.2 Lilly Business Overview
6.7.3 Lilly Anticoagulants Introduction
6.7.4 Lilly Anticoagulants Revenue in United States Market (2016-2021)
6.7.5 Lilly Recent Developments
6.8 Daiichi Sankyo
6.8.1 Daiichi Sankyo Company Details
6.8.2 Daiichi Sankyo Business Overview
6.8.3 Daiichi Sankyo Anticoagulants Introduction
6.8.4 Daiichi Sankyo Anticoagulants Revenue in United States Market (2016-2021)
6.8.5 Daiichi Sankyo Recent Developments
6.9 Otsuka
6.9.1 Otsuka Company Details
6.9.2 Otsuka Business Overview
6.9.3 Otsuka Anticoagulants Introduction
6.9.4 Otsuka Anticoagulants Revenue in United States Market (2016-2021)
6.9.5 Otsuka Recent Developments
6.10 AstraZeneca
6.10.1 AstraZeneca Company Details
6.10.2 AstraZeneca Business Overview
6.10.3 AstraZeneca Anticoagulants Introduction
6.10.4 AstraZeneca Anticoagulants Revenue in United States Market (2016-2021)
6.10.5 AstraZeneca Recent Developments
6.11 Pfizer
6.11.1 Pfizer Company Details
6.11.2 Pfizer Business Overview
6.11.3 Pfizer Anticoagulants Introduction
6.11.4 Pfizer Anticoagulants Revenue in United States Market (2016-2021)
6.11.5 Pfizer Recent Developments
6.12 Aspen
6.12.1 Aspen Company Details
6.12.2 Aspen Business Overview
6.12.3 Aspen Anticoagulants Introduction
6.12.4 Aspen Anticoagulants Revenue in United States Market (2016-2021)
6.12.5 Aspen Recent Developments
6.13 The Medicines Company
6.13.1 The Medicines Company Company Details
6.13.2 The Medicines Company Business Overview
6.13.3 The Medicines Company Anticoagulants Introduction
6.13.4 The Medicines Company Anticoagulants Revenue in United States Market (2016-2021)
6.13.5 The Medicines Company Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Anticoagulants Market Opportunities & Trends in United States Market
Table 2. Anticoagulants Market Drivers in United States Market
Table 3. Anticoagulants Market Restraints in United States Market
Table 4. Key Players of Anticoagulants in United States Market
Table 5. Top Anticoagulants Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Anticoagulants Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Anticoagulants Revenue Share by Companies, 2016-2021
Table 8. Companies Anticoagulants Product Type
Table 9. List of Tier 1 Anticoagulants Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Anticoagulants Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Anticoagulants Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Anticoagulants Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Anticoagulants Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Anticoagulants Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Anticoagulants Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Anticoagulants Revenue (US$, Mn), 2022-2027
Table 17. Sanofi Company Details
Table 18. Sanofi Business Overview
Table 19. Sanofi Anticoagulants Product
Table 20. Sanofi Anticoagulants Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Sanofi Recent Developments
Table 22. Bristol-Myers Squibb Company Details
Table 23. Bristol-Myers Squibb Business Overview
Table 24. Bristol-Myers Squibb Anticoagulants Product
Table 25. Bristol-Myers Squibb Anticoagulants Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Bristol-Myers Squibb Recent Developments
Table 27. Bayer Company Details
Table 28. Bayer Business Overview
Table 29. Bayer Anticoagulants Product
Table 30. Bayer Anticoagulants Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Bayer Recent Developments
Table 32. Johnson & Johnson. Company Details
Table 33. Johnson & Johnson. Business Overview
Table 34. Johnson & Johnson. Anticoagulants Product
Table 35. Johnson & Johnson. Anticoagulants Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Johnson & Johnson. Recent Developments
Table 37. Genentech (Roche) Company Details
Table 38. Genentech (Roche) Business Overview
Table 39. Genentech (Roche) Anticoagulants Product
Table 40. Genentech (Roche) Anticoagulants Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Genentech (Roche) Recent Developments
Table 42. Boehringer Ingelheim Company Details
Table 43. Boehringer Ingelheim Business Overview
Table 44. Boehringer Ingelheim Anticoagulants Product
Table 45. Boehringer Ingelheim Anticoagulants Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Boehringer Ingelheim Recent Developments
Table 47. Lilly Company Details
Table 48. Lilly Business Overview
Table 49. Lilly Anticoagulants Product
Table 50. Lilly Anticoagulants Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Lilly Recent Developments
Table 52. Daiichi Sankyo Company Details
Table 53. Daiichi Sankyo Business Overview
Table 54. Daiichi Sankyo Anticoagulants Product
Table 55. Daiichi Sankyo Anticoagulants Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Daiichi Sankyo Recent Developments
Table 57. Otsuka Company Details
Table 58. Otsuka Business Overview
Table 59. Otsuka Anticoagulants Product
Table 60. Otsuka Anticoagulants Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Otsuka Recent Developments
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Anticoagulants Product
Table 65. AstraZeneca Anticoagulants Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. AstraZeneca Recent Developments
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Anticoagulants Product
Table 70. Pfizer Anticoagulants Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Developments
Table 72. Aspen Company Details
Table 73. Aspen Business Overview
Table 74. Aspen Anticoagulants Product
Table 75. Aspen Anticoagulants Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. Aspen Recent Developments
Table 77. The Medicines Company Company Details
Table 78. The Medicines Company Business Overview
Table 79. The Medicines Company Anticoagulants Product
Table 80. The Medicines Company Anticoagulants Revenue in United States Market (2016-2021) & (US$ Million)
Table 81. The Medicines Company Recent Developments
List of Figures
Figure 1. Anticoagulants Segment by Type
Figure 2. Anticoagulants Segment by Application
Figure 3. United States Anticoagulants Market Overview: 2020
Figure 4. United States Anticoagulants Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Anticoagulants Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Anticoagulants Revenue in 2020
Figure 7. By Type - United States Anticoagulants Revenue Market Share, 2016-2027
Figure 8. By Application - United States Anticoagulants Revenue Market Share, 2016-2027
Figure 9. Sanofi Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Bristol-Myers Squibb Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Bayer Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Johnson & Johnson. Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Genentech (Roche) Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Boehringer Ingelheim Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Lilly Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Daiichi Sankyo Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Otsuka Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. AstraZeneca Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Pfizer Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Aspen Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. The Medicines Company Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs